
Discover our medicines
Our innovative medicines address society’s greatest disease burdens and restore possibility for patients.

Explore our science
Discover how we unravel the mysteries of biology and develop new technologies to fight disease and change lives.

Learn about our impact
Creating a medicine is just the beginning of the journey. Discover how we embrace societal impact as a core business objective.

Novartis 2024 Financial Results
Novartis announced the company’s fourth quarter and 2024 full year financial results.

Novartis in Society Integrated Report 2024
Read more about our performance against our business, environmental, social and governance (ESG) priorities in the Novartis in Society Integrated Report 2024.
Latest news
Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront
Novartis continues strong momentum of sales growth with margin expansion, reaches key innovation milestones in 2024
Novartis Entresto® US patent upheld by US Court of Appeals

Official partner of the Eurovision Song Contest 2025
Between May 10-17, 2025, Basel will host the Eurovision Song Contest and we are excited to be an official partner.